Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Clinical Insight

Qiagen has launched Qiagen Clinical Insight, a bioinformatics content and software platform that clinical testing laboratories can use to interpret and report on genomic variants identified in next-generation sequencing data.

According to the company, the Clinical Insight platform provides tools for evaluating genomic variants in the context of published biomedical literature, professional association guidelines, publicly available databases and annotations, drug labels, and clinical trials. It enables clinicians rapidly classify variants, identify treatment options, and match patients to clinical trials. It also provides access to the Allele Frequency Community, a large repository of ancestral and ethnic diversity data.

The platform currently supports somatic and hereditary cancer testing. 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.